Idhifa

Enasidenib Mesylate

What is Idhifa used for?

This medication is used to treat a certain type of blood cell cancer (acute myeloid leukemia-AML). Enasidenib works by helping your bone marrow grow normal blood cells so you will need fewer blood transfusions. This drug has been withdrawn from the Canadian market due to problems with effectiveness.

CHEMICAL NAME

Enasidenib Mesylate

DRUG TYPE

Cancer
InsideRx Coupon Icon

Get Idhifa Savings

Compare prices for Idhifa and save up to 80%.

Idhifa Frequently Asked Questions

Enasidenib has rarely caused a serious (possibly fatal) condition called differentiation syndrome. This condition may happen anytime during the first 5 months of treatment. Get medical help right away if you develop any signs of differentiation syndrome, such as fever, cough, shortness of breath, trouble breathing, bone pain, rapid weight gain, swelling of arms/legs, swelling around the neck/underarm/groin areas (swollen lymph nodes), dizziness/lightheadedness, fast heartbeat, or chest pain.

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Idhifa Dosage and Form Information

Tablet
100 Mg
50 Mg